Healing, Equity, Advocacy and Respect for Mamas (HEAR4Mamas)

February 12, 2026 updated by: Constance Guille, Medical University of South Carolina

Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits

The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The purpose of the study is to learn if a program for newborn mom's can improve detection of complications after delivery and help women get medical care quickly and easily. Participants will be asked to complete a survey at the time of enrollment and at 3 additional times. All surveys can be completed via cell-phone or email. All women will be followed for 1-year after delivery. Women that enroll will be assigned to one of two groups: usual in person care OR usual in-person care PLUS a text message-based program that will ask about sign and symptoms of complications that may occur after delivery. If there is a concern, a nurse advocate will call on the phone to discuss options and help refer to care if needed. Participants will be paid for their time in completing surveys.

Study Type

Interventional

Enrollment (Estimated)

2894

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Constance Guille, MD
  • Phone Number: 843-792-6489
  • Email: guille@musc.edu

Study Contact Backup

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Recruiting
        • Medical University of South Carolina
        • Contact:
          • Constance Guille, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for Postpartum Women

  • Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina.
  • Aged 16-49 years old.
  • Insured by Medicaid.

Exclusion Criteria for Postpartum Women

  • Plans to relocate outside of SC anytime during the postpartum year.
  • Plans to discontinue Medicaid health insurance during the postpartum year.
  • Speaks a language other than English or Spanish.
  • Incarcerated/pending incarceration during peripartum period.
  • Currently institutionalized.
  • Enrolled in current MUSC study funded by PCORI (#Pro00123833)
  • Does not have and/or does not wish to use their personal cell phone for the study.

Inclusion Criteria for Obstetric Providers and Hospital Administrators

- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit.

Exclusion Criteria for Obstetric Providers and Hospital Administrators

  • Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from.
  • Unable or unwilling to commit to completing surveys or an interview.
  • Speaking a language other than English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
AIM (AIM Alliance for Innovation on Maternal Health) safety bundles delivered in-person
Experimental: Usual Care plus H.E.A.R. for Mamas
H.E.A.R. for Mamas is designed to provide the AIM (Alliance for Innovation on Maternal Health) Postpartum Discharge Transition education systematically and to frequently monitor women for signs and symptoms of postpartum complications using simple, patient-centered technology (text/phone).
H.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency Department (ED) visits within six weeks postpartum
Time Frame: Within six weeks following the delivery
Percent of postpartum women with an ED visit that occurs within six weeks following delivery
Within six weeks following the delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Reported Outcomes (PROs)
Time Frame: time of study enrollment (baseline=0), and 3, 6, and 12 months postpartum
Secondary outcomes will include PROs which will be measured at the time of study enrollment (baseline=0), and 3, 6, and 12 months postpartum.
time of study enrollment (baseline=0), and 3, 6, and 12 months postpartum

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Determinants of Health (SDoH), Patient Activation, Shared Decision Making
Time Frame: HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum
SDoH will be measured by the Accountable Health Communities-Health-Related Social Needs (HRSN) and includes assessment of economic instability, low social support, food scarcity etc.
HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum
Patient Activation
Time Frame: HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum
Patient activation will be measured by the Patient Activation Measure (PAM-10).
HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum
Shared Decision Making
Time Frame: HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum
Perception of the shared decision-making process will be measured by Shared Decision-Making Questionnaire (SDM-Q-9).
HRSN, PAM-10, and SDM-Q-9 will be measured at study enrollment (baseline=0), 3, 6, and 12 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 28, 2024

Primary Completion (Estimated)

November 30, 2028

Study Completion (Estimated)

March 30, 2030

Study Registration Dates

First Submitted

January 27, 2024

First Submitted That Met QC Criteria

February 15, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 12, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Complication

Clinical Trials on H.E.A.R. for Mamas

Subscribe